These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 37396901)

  • 1. Long-term functional and structural outcomes in X-linked retinoschisis: implications for clinical trials.
    Fenner BJ; Russell JF; Drack AV; Dumitrescu AV; Sohn EH; Russell SR; Boldt HC; Affatigato LM; Hoffmann JM; Andorf JL; Stone EM; Han IC
    Front Med (Lausanne); 2023; 10():1204095. PubMed ID: 37396901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carbonic anhydrase inhibitors limit complications in X-linked retinoschisis.
    Wey S; Brill DA; Miraldi Utz V; Sisk RA
    Front Med (Lausanne); 2023; 10():1281068. PubMed ID: 38020097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. X-Linked Retinoschisis: Deep Phenotyping and Genetic Characterization.
    Georgiou M; Finocchio L; Fujinami K; Fujinami-Yokokawa Y; Virgili G; Mahroo OA; Webster AR; Michaelides M
    Ophthalmology; 2022 May; 129(5):542-551. PubMed ID: 34822951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Of men and mice: Human X-linked retinoschisis and fidelity in mouse modeling.
    Vijayasarathy C; Sardar Pasha SPB; Sieving PA
    Prog Retin Eye Res; 2022 Mar; 87():100999. PubMed ID: 34390869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morphological and functional parameters in X-linked retinoschisis patients-A multicentre retrospective cohort study.
    Kiraly P; Seitz IP; Abdalla Elsayed MEA; Downes SM; Patel CK; Charbel Issa P; Birtel J; Mautone L; Dulz S; Atiskova Y; Herrmann P; Vrabič N; Jarc-Vidmar M; Hawlina M; Fischer MD
    Front Med (Lausanne); 2023; 10():1331889. PubMed ID: 38351967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotype Heterogeneity and the Association Between Visual Acuity and Outer Retinal Structure in a Cohort of Chinese X-Linked Juvenile Retinoschisis Patients.
    Guo Q; Li Y; Li J; You Y; Liu C; Chen K; Li S; Lei B
    Front Genet; 2022; 13():832814. PubMed ID: 35309139
    [No Abstract]   [Full Text] [Related]  

  • 7. The Road towards Gene Therapy for X-Linked Juvenile Retinoschisis: A Systematic Review of Preclinical Gene Therapy in Cell-Based and Rodent Models of XLRS.
    van der Veen I; Heredero Berzal A; Koster C; Ten Asbroek ALMA; Bergen AA; Boon CJF
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38279267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A patient with X-linked retinoschisis and exudative retinal detachment associated with a pathogenic hemizygous variant c.304c>T in
    Tondelli NN; Mencaroni BM; Lemos CMB; Rocha de Sousa J; Sandoval Barbosa GC; Gomes AMV; da Palma MM
    Ophthalmic Genet; 2022 Dec; 43(6):871-875. PubMed ID: 36695495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genotype and phenotype characteristics of X-linked retinoschisis: the first report of a Turkish population.
    Cetin GO; Cetin EN; Akyol T; Ilhan HD; Pekel G
    Ophthalmic Genet; 2022 Jun; 43(3):318-325. PubMed ID: 34865595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. X-Linked Retinoschisis: Novel Clinical Observations and Genetic Spectrum in 340 Patients.
    Hahn LC; van Schooneveld MJ; Wesseling NL; Florijn RJ; Ten Brink JB; Lissenberg-Witte BI; Strubbe I; Meester-Smoor MA; Thiadens AA; Diederen RM; van Cauwenbergh C; de Zaeytijd J; Walraedt S; de Baere E; Klaver CCW; Ossewaarde-van Norel J; van den Born LI; Hoyng CB; van Genderen MM; Sieving PA; Leroy BP; Bergen AA; Boon CJF
    Ophthalmology; 2022 Feb; 129(2):191-202. PubMed ID: 34624300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. X-linked retinoschisis: mutation spectrum and genotype-phenotype relationship in an Italian pediatric cohort.
    Fortunato P; Pagliazzi A; Bargiacchi S; Marziali E; Sodi A; Caputo R; Passerini I; Pelo E; Bacci GM
    Ophthalmic Genet; 2023 Feb; 44(1):35-42. PubMed ID: 36377647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbonic anhydrase inhibition in X-linked retinoschisis: An eye on the photoreceptors.
    Ambrosio L; Williams JS; Gutierrez A; Swanson EA; Munro RJ; Ferguson RD; Fulton AB; Akula JD
    Exp Eye Res; 2021 Jan; 202():108344. PubMed ID: 33186570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term rearrangement of retinal structures in a novel mutation of X-linked retinoschisis.
    Piermarocchi S; Miotto S; Colavito D; Del Giudice E; Leon A; Maritan V; Piermarocchi R; Tormene AP
    Biomed Rep; 2017 Sep; 7(3):241-246. PubMed ID: 28811895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The dose-response relationship of subretinal gene therapy with rAAV2tYF-CB-h
    Hassan S; Hsu Y; Thompson JM; Kalmanek E; VandeLune JA; Stanley S; Drack AV
    Front Med (Lausanne); 2024; 11():1304819. PubMed ID: 38414621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical manifestation and genetic analysis in Chinese early onset X-linked retinoschisis.
    Huang L; Sun L; Wang Z; Chen C; Wang P; Sun W; Luo X; Ding X
    Mol Genet Genomic Med; 2020 Oct; 8(10):e1421. PubMed ID: 33460243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preclinical Dose-Escalation Study of Intravitreal AAV-RS1 Gene Therapy in a Mouse Model of X-linked Retinoschisis: Dose-Dependent Expression and Improved Retinal Structure and Function.
    Bush RA; Zeng Y; Colosi P; Kjellstrom S; Hiriyanna S; Vijayasarathy C; Santos M; Li J; Wu Z; Sieving PA
    Hum Gene Ther; 2016 May; 27(5):376-89. PubMed ID: 27036983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical findings and
    Chen C; Xie Y; Sun T; Tian L; Xu K; Zhang X; Li Y
    Mol Vis; 2020; 26():291-298. PubMed ID: 32300273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular modeling of retinoschisin with functional analysis of pathogenic mutations from human X-linked retinoschisis.
    Sergeev YV; Caruso RC; Meltzer MR; Smaoui N; MacDonald IM; Sieving PA
    Hum Mol Genet; 2010 Apr; 19(7):1302-13. PubMed ID: 20061330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular mechanisms leading to null-protein product from retinoschisin (RS1) signal-sequence mutants in X-linked retinoschisis (XLRS) disease.
    Vijayasarathy C; Sui R; Zeng Y; Yang G; Xu F; Caruso RC; Lewis RA; Ziccardi L; Sieving PA
    Hum Mutat; 2010 Nov; 31(11):1251-60. PubMed ID: 20809529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Null retinoschisin-protein expression from an RS1 c354del1-ins18 mutation causing progressive and severe XLRS in a cross-sectional family study.
    Vijayasarathy C; Ziccardi L; Zeng Y; Smaoui N; Caruso RC; Sieving PA
    Invest Ophthalmol Vis Sci; 2009 Nov; 50(11):5375-83. PubMed ID: 19474399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.